EAM
BSX icon

Exos Asset Management’s Boston Scientific BSX Stock Holding History

Exos Asset Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,035
Closed -$87K – 495
2021
Q2 		$87K Buy
+2,035
New +$85.6K 0.05% 370

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Exos Asset Management's BSX Position: Q3 2021 in Review

Exos Asset Management sold out of Boston Scientific (BSX) in Q3 2021, closing a stake of 2,035 shares — an estimated $87K sold.

Exos Asset Management first reported a position in BSX in Q2 2021 and held it in 1 quarter. The position peaked at $87K in Q2 2021. 877 funds tracked by Wall St. Rank hold BSX as of Q3 2021.

  • Exos Asset Management reported no remaining Boston Scientific position as of Q3 2021 after selling out during the quarter.
  • Exos Asset Management sold 2,035 Boston Scientific shares in Q3 2021, an estimated $87K.
  • Exos Asset Management first reported a position in Boston Scientific in Q2 2021 and held it in 1 quarter.
  • Exos Asset Management's Boston Scientific position peaked at $87K in Q2 2021.
  • 877 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2021.

Based on Exos Asset Management's 13F filing for Q3 2021, filed 25 Oct 2021.